Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

International Bio Recovery Corporation V.IBR



TSXV:IBR - Post by User

Post by Cayman3on Jun 14, 2004 12:27pm
221 Views
Post# 7608041

IBR Stock Option Grants

IBR Stock Option GrantsInternational Bio Recovery Corporation announces stock option grants Friday June 11, 4:00 pm ET TSX Venture Exchange symbol: IBR VANCOUVER, June 11 /CNW/ - International Bio Recovery Corporation ("IBR") (TSX-V: IBR - News) a biotech company with a proprietary technology to convert organic waste into environmentally progressive soil fertility products, today announced stock option grants. The Company has granted incentive stock options to senior employees and seven insiders to acquire a total of 2,015,000 common shares of the Company exercisable for a period of two years at a price of $0.50 per share, subject to the approval of the TSX Venture Exchange. Following this grant the Company will have a total of 2,395,000 incentive stock options outstanding. About IBR International Bio Recovery Corporation (IBR) has developed an environmental technology, which processes organic material from municipal solid waste, agricultural manures and surplus organics from food production into innovative, environmentally progressive fertility products. Located in North Vancouver, BC, IBR markets its technology products through the sale of licenses. The Company's current and medium term focus is to further develop its marketing capacity to enhance technology license sales. The Company is committed to research and development to continue to improve the effectiveness of its technology and the quality of its fertility products. It is further committed to developing a world wide marketing capability to ensure market acceptance of its fertility products. https://www.newswire.ca/en/releases/orgDisplay.cgi?okey=35806 For further information please contact: Elmer B. Friesen, President & CEO, IBR, (604) 924-1023 ext 308, (604) 924-1043 fax, info@ibrcorp.com Henry J. Bow, Manager Corporate Relations, IBR, (604) 924-1023 ext 309, (604) 924-1043 fax, hbow@ibrcorp.com David Mason, Investor Relations, The Equicom Group Inc., (416) 815-0700 ext. 237, (416) 815-0080 fax, dmason@equicomgroup.com
Bullboard Posts